Rapid identification of bacteria from positive blood cultures by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene
Cy. Turenne et al., Rapid identification of bacteria from positive blood cultures by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene, J CLIN MICR, 38(2), 2000, pp. 513-520
Bacteremia continues to result in significant morbidity and mortality, part
icularly in patients who are immunocompromised, Currently, patients with su
spected bacteremia are empirically administered broad-spectrum antibiotics,
as definitive diagnosis relies upon the use of blood cultures, which impos
e significant delays in and limitations to pathogen identification. To addr
ess the limitations of growth-based identification, the sequence variabilit
y of the 16S rRNA gene of bacteria was targeted for rapid identification of
bacterial pathogens isolated directly from blood cultures using a fluoresc
ence-based PCR-single-st and conformation polymorphism (SSCP) protocol. Spe
cies-specific SSCP patterns were determined for 25 of the most common bacte
rial species isolated from blood cultures; these isolates subsequently serv
ed as a reference collection for bacterial identification for new cases of
bacteremia. A total of 272 blood-culture-positive patient specimens contain
ing bacteria were tested. A previously determined SSCP pattern was observed
for 251 (92%) specimens, with 21 (8%) specimens demonstrating SSCP pattern
s distinct from those in the reference collection. Time to identification f
rom blood culture positivity ranged from 1 to 8 days with biochemical testi
ng, whereas identification by fluorescence-based capillary electrophoresis
was obtained as early as 7 h at a calculated cost of $10 (U.S. currency) pe
r specimen when tested in batches of 10. Limitations encountered included t
he inability to consistently detect mixed cultures as,well as some species
demonstrating identical SSCP patterns. This method can be applied directly
to blood cultures or whole-blood specimens, where early pathogen identifica
tion would result in a timely diagnosis with possible implications for pati
ent management costs and the mortality and morbidity of infections.